close

Amid US watchdog heat, it is life as usual at Global Pharma'S Chennai unit

The firm ran into trouble after the US FDA informed it of 55 cases of adverse events on the use of its eye drops, some of which caused permanent loss of vision and at least one caused death

Shine Jacob Chennai
Global Pharma unit
Premium

Global Pharma Healthcare unit

Listen to This Article

The air in and around SIDCO Pharmaceutical Complex at Alathur, some 52 km from Chennai, is filled with odours generated from various organic and inorganic compounds.
Or

Also Read

After Gambia, now Uzbekistan alleges Indian cold drug killed its children

Chennai-based firm's eye drops contaminated, says US FDA report

Role of Maiden Pharma cough syrups in Gambia kids' deaths not confirmed

Analysts turn cautious on Cipla as US FDA action delays key US launches

After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups

Honda Motor announces top management changes its Indian two-wheeler arm

Cyient shares jump 5% in mid-session trade after firm rejigs top leadership

Waaree Renewable Tech bags order to build 221.8 MW solar power project

Amp Energy to set up 1 GW capacity under PLI scheme for manufacturing

IKF Finance raises Rs 250 cr from Accion's Digital Transformation Fund

First Published: Apr 05 2023 | 3:57 PM IST

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com